Overjet, the dental industry leader in artificial intelligence, announced on June 28 its fourth FDA clearance, expanding the use of its AI technology for predicting tooth decay in younger patients.
The Food and Drug Administration analyzed and approved Overjet's AI models for detecting and outlining caries on periapical radiographs and bitewing radiographs for patients aged 12 and older who have permanent teeth.
The FDA study found dentists were able to detect more carious lesions when using Overjet. Specifically, dentists missed 43% fewer teeth with caries on bitewing images and 45.8% fewer teeth with caries on periapical images.
This helps dentists with their diagnosis, treatment planning and discussions with patients. Overjet is the only dental AI technology that outlines the decay, which helps both providers and patients visualize the extent more clearly.
"Untreated cavities can lead to problems with eating, speaking, self-esteem, and quality of life," said Wardah Inam, the CEO and co-founder of Overjet, in a news release. "Our goal is to improve oral health care for all, and expanding Overjet's AI detection capabilities gives dentists another advantage to help provide the best care possible."
Overjet's previous FDA clearance for Caries Assist was recognized by Fast Company as a world-changing idea for 2023. Overjet is also FDA-cleared to detect calculus and to quantify bone level measurements. It adds metrics that help providers determine the level of periodontal or gum disease, and help patients visualize how the infection is deteriorating the bone supporting their teeth.
Overjet continues to raise the bar for optimal patient health. One of the benefits of artificial intelligence is that it can process large amounts of data quickly. Overjet's AI integrates with the digital imaging and practice management systems to analyze patient records from previous appointments and provide additional insights to assist in patient care.
To learn more about how Overjet is elevating dental care, visit overjet.com.
About Overjet
Founded by experts from MIT and Harvard School of Dentistry, Overjet is the industry leader in dental artificial intelligence, helping both providers and payers improve patient care. By combining deep expertise in dentistry and advanced engineering, Overjet develops accurate and quantified ways to detect pathologies and integrates actionable insights into clinical and operational workflows. Every day, dental groups (DSOs), private dental practices, and dental payers rely on the information provided by Overjet to enhance patient care. To learn more, visit overjet.com.
Products 19 November 2026
FDA Grants Breakthrough Designation to OraLiva Oral Cancer Test
Investigational cytology test is designed to help clinicians assess suspicious oral lesions with a quantitative index.
News 11 May 2026
Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10, 2026.
Products 22 December 2025
AI dental company announces 510(k) clearance from the U.S. Food and Drug Administration for Overjet CBCT Assist.
News 05 November 2025
Perimetrics, Inc., a dental technology company pioneering quantitative diagnostics, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the InnerView...
Products 26 November 2024
DentalMonitoring Enhances Orthodontic Software With FDA-Cleared AI Technology
DentalMonitoring, the leader in artificial intelligence (AI)-powered remote monitoring for orthodontics, has released a major software update introducing features and indications based on the...
Products 20 November 2026
Key features include intuitive usability, highlighted by an integrated display that enhances patient understanding of scan results and supports informed treatment decisions.
News 20 November 2026
New Service Combines In-Office Photography, Custom Creative Content, and a Yearlong Posting Plan to Help Patients Get to Know the People Behind Their Care
News 20 November 2026
Dr. Cesar Tapia Awarded American College of Dentists Fellowship
Cesar Tapia, founder of ConfiDENT in Alpharetta and Cumming, Georgia, was awarded Fellowship in the American College of Dentists on October 24, 2026, during the College’s Annual Me
Editorials 20 November 2026
When the Food and Drug Administration issued a safety warning in 2022 about severe tooth decay associated with a commonly prescribed orally dissolving opioid use disorder medicatio
Prosthodontics 20 November 2026
This peer-reviewed prosthodontics article summarizes clinical evidence from BMC oral health (2025). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...